A breakdown in the supply chain ofsodium bicarbonate the same basic compound as household baking soda for use in medical procedures is expected to limit access to certain treatments in hospitals through the end of the year.
A shortage of the antacid is prompting health care providers to carefully prioritize procedures, delay some operations and choose alternative treatments in some instances.
The crisis is directly connected to troubles at a supplier of pharmaceuticals giant Pfizer, but it has rippled through the medical sector, which relies on it to treat various conditions including drug overdoses and acidosis. The shortages also could affect patients facing severe renal disease, diabetes, severe dehydration and cardiac arrest.
“Drug shortages have this potential to compromise” the need for immediate care, said Sandra Kane-Gill, chair of the medication use safety committee at the Society of Critical Care Medicine. “It does have potential patient safety implications.”
Hot Medical Stocks To Invest In Right Now: Trinity Industries Inc.(TRN)
- [By Jon C. Ogg]
Also seen aswinners are equipment and fixtures makers, from construction to rail to transports. Trinity Industries Inc. (NYSE: TRN), largely considered a rail winner, was up 1.4% at $27.20 late on Monday.
- [By Lisa Levin]
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.
Hot Medical Stocks To Invest In Right Now: Green Mountain Coffee Roasters Inc.(GMCR)
- [By David Sterman]
But for short sellers in Green Mountain Coffee Roasters (Nasdaq: GMCR), there's another outcome: They've been badly burned as shares have surged, but they insist they've been right all along, and it's only a matter of time before the stock crashes and burns.
- [By Jonas Elmerraji]
As badly as short sellers want to hate on Green Mountain Coffee Roasters (GMCR), betting against the multiyear rally in this $12.7 billion beverage stock has been about as wise as eating from a box with a skull and crossbones on it. And as a bull market continues to lift all ships, Green Mountain’s ship is going to keep floating above the others.
Green Mountain owns Keurig, the brand of beverage brewers that use self-contained K-Cups to make coffee, teas, and other drinks. While Keurig’s “fad” status has certainly helped tip the deck against GMCR, the fact remains that the firm has done most of the hard work in getting Keurig machines accepted by consumers. With brewers essentially ubiquitous at this point, the firm is able to make money on its cash cow: the K-Cups.
Keurig’s individual-serving cups have big margins and a big installed base. With huge convenience and the relatively large sunk cost that consumers have put into their Keurig machines, it’s a sticky business with big switching costs. Consumers who buy a Keurig are much less likely to spend the money on a competing brand of proprietary coffee pods.
I’ve said before that GMCR is far from cheap right now. But its momentum trajectory is showing few signs of fizzling out, especially as direct competitors such as Starbucks (SBUX) continue to sell K-Cups of their own. Don’t bet against GMCR in September – buy this Rocket Stock instead.
- [By Canadian Value]
So Im going to stick my next out and share my views on four battleground stocks that are among my favorite shorts: World Acceptance (WRLD), Green Mountain (GMCR), Herbalife (HLF), and InterOil (IOC). And next week at the Value Investing Congress I will present another short, my largest.
Hot Medical Stocks To Invest In Right Now: Ring Energy, Inc.(REI)
- [By Monica Gerson]
Ring Energy Inc (NYSE: REI) is projected to post a quarterly loss at $0.05 per share on revenue of $7.92 million.
Gain Capital Holdings Inc (NYSE: GCAP) is estimated to post its quarterly earnings at $0.07 per share on revenue of $100.39 million.
Hot Medical Stocks To Invest In Right Now: Norsat International Inc.(NSAT)
- [By Lisa Levin]
Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.